Johnson and Johnson exit the bid to acquire Pfizer’s consumer unit

By Catherine Sturman
Global pharmaceutical giant Johnson and Johnson have exited its bid to acquire Pfizer’s consumer unit, which it previously acquired back in 2006. The...

Global pharmaceutical giant Johnson and Johnson have exited its bid to acquire Pfizer’s consumer unit, which it previously acquired back in 2006. The decision has come as a surprise, yet competitors GlaxoSmithKline (GSK) and Reckitt Benckiser remain in the running.

Bidders have until the 1 February to submit an offer, yet bidders will have to dig deep in their pockets. It has been reported that the business is wanting bids no less than $20 billion.

Nonetheless, competition is to acquire the unit is not only of the interest of pharmaceutical giants. With a faithful customer base surrounding its over-the-counter drugs, such as Advil and Centrum, many industries are exploring the potential of investing in healthcare and what it could bring in terms of future growth.

See also

It has been reported that Swiss confectionary company Nestle is looking at bidding for the division, which would support the company’s growing healthcare focus. It has recently sold its US confectionary business to Ferrero for $2.8 billion, further highlighting the company’s change in strategy.

However, for pharmaceutical companies, the acquisition could make the successful bidder a significant player in the consumer health market, an area which is growing year on year amidst an increasing tech-savvy market.

 

Share

Featured Articles

Digital healthcare platform Balanced supports healthy ageing

10,000 people turn 65 in the USA each day. Digital healthcare platform Balanced wants to help them better manage healthy ageing, says CEO Katie Reed

TrueBinding’s antibody drugs fight Alzheimer’s Disease

Dongxu Sun, CEO at TrueBinding, shares how its research & antibody drug development is fighting illnesses such as Alzheimer’s Disease, stroke & more

Cardinal Health’s clinically integrated pharma supply chain

Peter J. Siavelis, SVP & General Manager, Health System & Provider Distribution & Services at Cardinal Health, discusses the integrated pharma supply chain

Healthcare Digital news roundup: digital healthcare & AI

Digital Healthcare

Hospitals must embrace IoMT device security

Hospitals

Mental health support for working women and mothers

Digital Healthcare